ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,660.06
      1.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      01/07/20164:02PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/06/201610:08PMGlobeNewswire Inc.Adamas Announces Pricing of Public Offering of Common StockNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/06/20166:05AMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/06/20166:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/05/20167:15AMGlobeNewswire Inc.Adamas Announces Proposed Public Offering of Common StockNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/05/20167:10AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/24/20156:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/23/20156:00AMGlobeNewswire Inc.Adamas Announces Positive Top-Line Phase 3 Results of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients W...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/22/20155:24PMGlobeNewswire Inc.Adamas to Host Conference Call and Webcast to Provide Company UpdateNASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/14/20154:05PMGlobeNewswire Inc.Adamas Completes Enrollment of Its Phase 3 EASE LID 3 Study Evaluating ADS-5102 for Treatment of Levodopa-Induced Dyskinesia ...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/10/20154:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/09/20155:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/17/20154:05PMGlobeNewswire Inc.Adamas Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/12/20155:41PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/12/20154:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/12/20154:05PMGlobeNewswire Inc.Adamas Reports Third Quarter 2015 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/04/20155:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/27/20154:05PMGlobeNewswire Inc.Adamas Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/12/20154:00PMGlobeNewswire Inc.Adamas Presents Nonclinical Findings Supporting the Potential Use of ADS-5102 for the Treatment of Multiple Sclerosis GaitNASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/07/20155:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/10/20156:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/10/20157:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/24/20155:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/11/20154:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/11/20154:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/05/20156:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/09/20154:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/09/20154:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/08/20154:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/22/20157:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS